University of California San Francisco

News & Events

Displaying 33 - 41 of 41

Transplant and Stem Cell Immunobiology (TSI) Lab
February 26, 2019
Technique Prevents Transplant Rejection in the Lab, a Major Advance for Stem Cell Therapies Human heart muscle cells derived from triple-engineered stem cells that are “invisible” to the immune system. The red is troponin, a protein that participates in cardiac muscle contraction. The blue is the cell’s nucleus...

UCSF Department of Surgery
February 24, 2018
Johannes R. Kratz, M.D. has been named the new Van Auken Endowed Chair in Thoracic Oncology. Kratz is an assistant professor in the Division of Adult Cardiothoracic Surgery, a member of the Thoracic Oncology Program, and director of Advanced Minimally Invasive Thoracic Surgery. The Van Auken Endowed Chair supports...
Deuse Tobias 2 Square

UCSF Cardiothoracic Surgery
January 26, 2018
Tobias Deuse, M.D., associate professor of surgery and director of minimally-invasive cardiac surgery at UCSF, has been named The Julien I. E. Hoffman, M.D. Chair in Cardiac Surgery. Dr. Deuse, a cardiac and heart transplant surgeon, is internationally renowned for his pioneering work in the development of...

UCSF Thoracic Oncology Program
November 07, 2014
Building on earlier retrospective validation studies , a team of Thoracic Oncology Program researchers, demonstrated in a small prospective study the clinical utility of a 14-gene expression assay in stratifying risk among non-small cell lung cancer (NSCLC) patients. In a recently published paper in the journal...

Cardiac Biomechanics Lab
January 16, 2014
Dr. Julius Guccione, a biomedical engineer and co-director of the UCSF Cardiac Biomechanics Lab, lauded the development of technology rendering a virtual image of a beating heart by Dassault Systèmes, a French design and simulation software company. Dassault has developed a complete, three-dimensional view of the...
David M. Jablons - 144

UCSF Thoracic Oncology Program
January 26, 2012
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team, led by UCSF thoracic surgeons David M. Jablons, M.D. and Michael Mann, M.D., demonstrated that a 14-gene prognostic molecular assay better predicted the likelihood of death in early-stage lung cancer...